Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Receivables - Other (2017 - 2019)

Historic Receivables - Other for CollPlant Biotechnologies (CLGN) over the last 3 years, with Q4 2019 value amounting to $270000.0.

  • CollPlant Biotechnologies' Receivables - Other fell 1916.17% to $270000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $270000.0, marking a year-over-year decrease of 1916.17%. This contributed to the annual value of $270000.0 for FY2019, which is 1916.17% down from last year.
  • According to the latest figures from Q4 2019, CollPlant Biotechnologies' Receivables - Other is $270000.0, which was down 1916.17% from $334000.0 recorded in Q4 2018.
  • CollPlant Biotechnologies' 5-year Receivables - Other high stood at $1.0 million for Q4 2017, and its period low was $270000.0 during Q4 2019.
  • For the 3-year period, CollPlant Biotechnologies' Receivables - Other averaged around $542000.0, with its median value being $334000.0 (2018).
  • In the last 5 years, CollPlant Biotechnologies' Receivables - Other plummeted by 6731.9% in 2018 and then plummeted by 1916.17% in 2019.
  • Quarter analysis of 3 years shows CollPlant Biotechnologies' Receivables - Other stood at $1.0 million in 2017, then plummeted by 67.32% to $334000.0 in 2018, then decreased by 19.16% to $270000.0 in 2019.
  • Its Receivables - Other was $270000.0 in Q4 2019, compared to $334000.0 in Q4 2018 and $1.0 million in Q4 2017.